Questa traduzione è in preparazione. Nel frattempo mostriamo temporaneamente la versione originale in inglese.
Imprese · 07/07/20041 min di lettura
Determination of Regulatory Review Period for Purposes of Patent Extension; NEUTERSOL
Traduzione automatica locale · Lingua originale della fonte
Riepilogo
The Food and Drug Administration (FDA) has determined the regulatory review period for NEUTERSOL and is publishing this notice of that determination as required by law. FDA has made the determination because of the submission of two applications to the Director of Patents and Trademarks, Department of Commerce, for the extension of two patents which claim that animal drug product.
Lingua originale della fonte: Federal Register — Food and Drug AdministrationApri il comunicato originale →